Rain Oncology Inc. Increase (Decrease) in Other Accrued Liabilities
Rain Oncology Inc. reported Increase (Decrease) in Other Accrued Liabilities of -$2.08 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2023-11-09
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for the quarter ending 2023-09-30 was -$796.00K, a 158.53% decline year-over-year.
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for the quarter ending 2023-06-30 was $1.14M.
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for the quarter ending 2023-03-31 was -$2.43M.
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for the quarter ending 2022-12-31 was $2.01M, a 52.78% decline year-over-year.
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for fiscal 2022 was $1.73M, a 19.50% decline from fiscal 2021.
- Rain Oncology Inc. increase (decrease) in other accrued liabilities for fiscal 2021 was $2.14M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$796.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $342.00K derived: sum of 2 quarters · filed 2023-11-09 | -$2.08M 10-Q · filed 2023-11-09 | -$72.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.29M 10-Q · filed 2023-08-10 | $724.00K derived: sum of 3 quarters · filed 2023-08-10 | $2.08M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$2.43M 10-Q · filed 2023-05-11 | -$414.00K derived: sum of 2 quarters · filed 2023-05-11 | $946.00K derived: sum of 3 quarters · filed 2023-11-09 | $518.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $3.37M derived: sum of 2 quarters · filed 2023-11-09 | $2.94M derived: sum of 3 quarters · filed 2023-11-09 | $1.73M 10-K · filed 2023-03-09 |
| 2022-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $932.00K derived: sum of 2 quarters · filed 2023-11-09 | -$286.00K 10-Q · filed 2023-11-09 | $3.98M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.65M 10-Q · filed 2023-08-10 | $2.62M derived: sum of 3 quarters · filed 2023-08-10 | -$68.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$1.22M 10-Q · filed 2023-05-11 | $3.04M derived: sum of 2 quarters · filed 2023-05-11 | $360.00K derived: sum of 3 quarters · filed 2023-05-11 | $69.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.58M derived: sum of 2 quarters · filed 2023-03-09 | $1.29M derived: sum of 3 quarters · filed 2023-03-09 | $2.14M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$2.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.97M derived: sum of 2 quarters · filed 2022-11-10 | -$2.12M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $566.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $857.00K 10-Q · filed 2022-05-04 | |||
| 2020-09-30 | $146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $438.00K derived: sum of 2 quarters · filed 2021-11-10 | $63.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $292.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$83.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | -$375.00K 10-Q · filed 2021-05-25 |